← Back to patent-cliff list
Valproic acid (Cereno Scientific)
Tier C — Watch / tradeValproic acid (Cereno Scientific)
Cereno Scientific Ab
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：HDAC
Indications (approved)：Pulmonary arterial hypertension, Thrombosis
Regional status
US
Phase II
2025-12-08
EU
Phase II
2022-05-05
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Valproic acid (Cereno Scientific)?
Approved indications include: Pulmonary arterial hypertension, Thrombosis.
When does the Valproic acid (Cereno Scientific) patent expire?
No public expiry year is available for Valproic acid (Cereno Scientific) yet; this page updates once verified.
How do I get a quote for Valproic acid (Cereno Scientific) intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-05